ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
Author:
Publisher
Frontiers Media SA
Subject
Cognitive Neuroscience,Aging
Reference102 articles.
1. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.;Abe;Amyotroph. Lateral Scler. Frontotemporal Degener.,2014
2. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.;Adhihetty;Neuromolecular Med.,2008
3. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.;Aggarwal;Lancet Neurol.,2010
4. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group.;ALS CNTF Treatment Study Group;Clin. Neuropharmacol.,1995
5. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis.;ALS CNTF Treatment Study Group;Neurology,1996
Cited by 323 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases;Nano Today;2024-04
2. Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes;Acta Pharmacologica Sinica;2024-01-29
3. Analyzing the ER stress response in ALS patient derived motor neurons identifies druggable neuroprotective targets;Frontiers in Cellular Neuroscience;2024-01-19
4. Generation of Human Induced Pluripotent Stem Cell (hiPSC)-Derived Astrocytes for Amyotrophic Lateral Sclerosis and Other Neurodegenerative Disease Studies;BIO-PROTOCOL;2024
5. New insight on microglia activation in neurodegenerative diseases and therapeutics;Frontiers in Neuroscience;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3